FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136631970> ?p ?o ?g. }

• W3136631970 endingPage "750" @default.
• W3136631970 startingPage "739" @default.
• W3136631970 abstract "The aim of this study was to examine the effect of CYP2C19 genotype on clinical outcomes in patients with coronary artery disease (CAD) who predominantly underwent percutaneous coronary intervention (PCI), comparing those treated with ticagrelor or prasugrel versus clopidogrel.The effect of CYP2C19 genotype on treatment outcomes with ticagrelor or prasugrel compared with clopidogrel is unclear.Databases through February 19, 2020, were searched for studies reporting the effect of CYP2C19 genotype on ischemic outcomes during ticagrelor or prasugrel versus clopidogrel treatment. Study eligibility required outcomes reported for CYP2C19 genotype status and clopidogrel and alternative P2Y12 inhibitors in patients with CAD with at least 50% undergoing PCI. The primary analysis consisted of randomized controlled trials (RCTs). A secondary analysis was conducted by adding non-RCTs to the primary analysis. The primary outcome was a composite of cardiovascular death, myocardial infarction, stroke, stent thrombosis, and severe recurrent ischemia. Meta-analysis was conducted to compare the 2 drug regimens and test interaction with CYP2C19 genotype.Of 1,335 studies identified, 7 RCTs were included (15,949 patients, mean age 62 years; 77% had PCI, 98% had acute coronary syndromes). Statistical heterogeneity was minimal, and risk for bias was low. Ticagrelor and prasugrel compared with clopidogrel resulted in a significant reduction in ischemic events (relative risk: 0.70; 95% confidence interval: 0.59 to 0.83) in CYP2C19 loss-of-function carriers but not in noncarriers (relative risk: 1.0; 95% confidence interval: 0.80 to 1.25). The test of interaction on the basis of CYP2C19 genotype status was statistically significant (p = 0.013), suggesting that CYP2C19 genotype modified the effect. An additional 4 observational studies were found, and adding them to the analysis provided the same conclusions (p value of the test of interaction <0.001).The effect of ticagrelor or prasugrel compared with clopidogrel in reducing ischemic events in patients with CAD who predominantly undergo PCI is based primarily on the presence of CYP2C19 loss-of-function carrier status. These results support genetic testing prior to prescribing P2Y12 inhibitor therapy." @default.
• W3136631970 created "2021-03-29" @default.
• W3136631970 creator A5004913924 @default.
• W3136631970 creator A5007593170 @default.
• W3136631970 creator A5008572738 @default.
• W3136631970 creator A5019471027 @default.
• W3136631970 creator A5024567376 @default.
• W3136631970 creator A5029129626 @default.
• W3136631970 creator A5037957960 @default.
• W3136631970 creator A5041673841 @default.
• W3136631970 creator A5043621364 @default.
• W3136631970 creator A5047187243 @default.
• W3136631970 creator A5052786582 @default.
• W3136631970 creator A5058110169 @default.
• W3136631970 creator A5058122974 @default.
• W3136631970 creator A5072898800 @default.
• W3136631970 creator A5085007326 @default.
• W3136631970 date "2021-04-01" @default.
• W3136631970 modified "2023-10-17" @default.
• W3136631970 title "Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy" @default.
• W3136631970 cites W1247968195 @default.
• W3136631970 cites W1520464148 @default.
• W3136631970 cites W1600041372 @default.
• W3136631970 cites W1882215761 @default.
• W3136631970 cites W1964551540 @default.
• W3136631970 cites W1985059672 @default.
• W3136631970 cites W1994351107 @default.
• W3136631970 cites W2017294431 @default.
• W3136631970 cites W2017468832 @default.
• W3136631970 cites W2019271482 @default.
• W3136631970 cites W2030352776 @default.
• W3136631970 cites W2087691066 @default.
• W3136631970 cites W2098923148 @default.
• W3136631970 cites W2107328434 @default.
• W3136631970 cites W2128228188 @default.
• W3136631970 cites W2129142764 @default.
• W3136631970 cites W2140501627 @default.
• W3136631970 cites W2149774429 @default.
• W3136631970 cites W2159858918 @default.
• W3136631970 cites W2164386459 @default.
• W3136631970 cites W2169387542 @default.
• W3136631970 cites W2194923682 @default.
• W3136631970 cites W2513072880 @default.
• W3136631970 cites W2519976161 @default.
• W3136631970 cites W2564134487 @default.
• W3136631970 cites W2588681363 @default.
• W3136631970 cites W2605783173 @default.
• W3136631970 cites W2744085351 @default.
• W3136631970 cites W2766537985 @default.
• W3136631970 cites W2796026345 @default.
• W3136631970 cites W2874098584 @default.
• W3136631970 cites W2936489929 @default.
• W3136631970 cites W2951424940 @default.
• W3136631970 cites W2971165578 @default.
• W3136631970 cites W2971992346 @default.
• W3136631970 cites W3010345443 @default.
• W3136631970 cites W3013767402 @default.
• W3136631970 cites W3080963011 @default.
• W3136631970 cites W3094055592 @default.
• W3136631970 cites W3162195278 @default.
• W3136631970 cites W4251834302 @default.
• W3136631970 doi "https://doi.org/10.1016/j.jcin.2021.01.024" @default.
• W3136631970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33744207" @default.
• W3136631970 hasPublicationYear "2021" @default.
• W3136631970 type Work @default.
• W3136631970 sameAs 3136631970 @default.
• W3136631970 citedByCount "83" @default.
• W3136631970 countsByYear W31366319702021 @default.
• W3136631970 countsByYear W31366319702022 @default.
• W3136631970 countsByYear W31366319702023 @default.
• W3136631970 crossrefType "journal-article" @default.
• W3136631970 hasAuthorship W3136631970A5004913924 @default.
• W3136631970 hasAuthorship W3136631970A5007593170 @default.
• W3136631970 hasAuthorship W3136631970A5008572738 @default.
• W3136631970 hasAuthorship W3136631970A5019471027 @default.
• W3136631970 hasAuthorship W3136631970A5024567376 @default.
• W3136631970 hasAuthorship W3136631970A5029129626 @default.
• W3136631970 hasAuthorship W3136631970A5037957960 @default.
• W3136631970 hasAuthorship W3136631970A5041673841 @default.
• W3136631970 hasAuthorship W3136631970A5043621364 @default.
• W3136631970 hasAuthorship W3136631970A5047187243 @default.
• W3136631970 hasAuthorship W3136631970A5052786582 @default.
• W3136631970 hasAuthorship W3136631970A5058110169 @default.
• W3136631970 hasAuthorship W3136631970A5058122974 @default.
• W3136631970 hasAuthorship W3136631970A5072898800 @default.
• W3136631970 hasAuthorship W3136631970A5085007326 @default.
• W3136631970 hasBestOaLocation W31366319701 @default.
• W3136631970 hasConcept C126322002 @default.
• W3136631970 hasConcept C140840227 @default.
• W3136631970 hasConcept C164705383 @default.
• W3136631970 hasConcept C168563851 @default.
• W3136631970 hasConcept C2777028646 @default.
• W3136631970 hasConcept C2777849778 @default.
• W3136631970 hasConcept C2778213512 @default.
• W3136631970 hasConcept C2780400711 @default.
• W3136631970 hasConcept C2780890252 @default.
• W3136631970 hasConcept C44249647 @default.
• W3136631970 hasConcept C45393284 @default.

• next